Childhood Immune Thrombocytopenia (ITP)

Childhood Immune Thrombocytopenia (ITP) is an autoimmune blood disorder in which the body's immune system mistakenly attacks and destroys platelets, reducing their number in the bloodstream. Platelets are essential for normal blood clotting, so a low platelet count increases the risk of bruising and bleeding. ITP commonly affects children between two and ten years of age and often develops after a viral infection.

The condition may cause easy bruising, tiny red or purple spots on the skin (petechiae), frequent nosebleeds, bleeding gums, or prolonged bleeding from minor cuts. Most children appear otherwise healthy, and severe internal bleeding is uncommon.

Diagnosis involves a physical examination, medical history, and blood tests showing isolated thrombocytopenia while other blood cell counts remain normal. Additional tests may be recommended if another underlying condition is suspected.

Many children with mild ITP recover without treatment within six to twelve months. When bleeding is significant or platelet levels are extremely low, treatment may include corticosteroids, intravenous immunoglobulin (IVIG), or anti-D immunoglobulin in suitable cases. Rarely, chronic ITP requires additional therapies.

Regular monitoring, avoiding high-risk activities, and seeking immediate medical care for severe bleeding or head injuries help ensure a safe recovery. Most children regain normal platelet counts and lead healthy, active lives with proper medical follow-up.